![Scott M. Horvitz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott M. Horvitz
Amministratore Delegato presso Opertech Bio, Inc.
Posizioni attive di Scott M. Horvitz
Società | Posizione | Inizio | Fine |
---|---|---|---|
Linguagen Corp.
![]() Linguagen Corp. Pharmaceuticals: OtherHealth Technology Linguagen Corp. researches and develops oral medicines. The firm also develops taste blockers and enhancers. The company was founded by Robert Margolskee in 1995 and is headquartered in Cranbury, NJ. | Direttore Finanziario/CFO | - | - |
Opertech Bio, Inc.
![]() Opertech Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opertech Bio, Inc. provides taste testing solutions for food, beverage, flavor ingredients, pet food, and pharmaceutical industries. Its technology can be used to discover new flavor ingredients, measure palatability, and optimize flavor formulations. The firm has developed taste evaluation technology called Microtiter Operant Gustometer, or MOG, an automated high throughput system for rapid characterization of taste sensory properties. The company was founded by Scott M. Horvitz and R. Kyle Palmer and is headquartered in Philadelphia, PA. | Amministratore Delegato | - | - |
Fondatore | - | - | |
Presidente | - | - |
Storia della carriera di Scott M. Horvitz
Precedenti posizioni note di Scott M. Horvitz
Società | Posizione | Inizio | Fine |
---|---|---|---|
REDPOINT BIO CORPORATION | Comptroller/Controller/Auditor | 14/04/2011 | 08/06/2012 |
Amministratore Delegato | 12/03/2007 | 01/12/2016 | |
Direttore Finanziario/CFO | 12/03/2007 | 01/12/2016 | |
Presidente | 12/03/2007 | 01/12/2016 | |
Segretario Aziendale | 12/03/2007 | 01/12/2016 | |
Treasurer | 12/03/2007 | 01/12/2016 | |
Protez Pharmaceuticals, Inc.
![]() Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Protez Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It develops antibiotics for infections & provides research service on intravenous & oral small molecule antibiotics to chronic and recurrent infections. The company was founded by Klaus Esser, Luigi Xerri & Christopher M. Cashman in 2003 and is headquartered in Malvern, PA. | Direttore/Membro del Consiglio | 01/01/2004 | 01/01/2008 |
Robcor Properties, Inc. | Direttore Finanziario/CFO | 12/03/2007 | 05/07/2007 |
Segretario Aziendale | 12/03/2007 | 05/07/2007 | |
Treasurer | 12/03/2007 | 05/07/2007 | |
Redpoint Bio Corp. /Old/ | Direttore Finanziario/CFO | 01/08/2003 | 01/06/2004 |
Segretario Aziendale | 01/08/2003 | 01/06/2004 | |
Treasurer | 01/08/2003 | 01/06/2004 | |
3-Dimensional Pharmaceuticals, Inc.
![]() 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | Direttore Finanziario/CFO | 01/01/1993 | 01/07/2003 |
Segretario Aziendale | 01/01/1993 | 01/07/2003 | |
Treasurer | 01/01/1993 | 01/07/2003 | |
Genaera Corp.
![]() Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Direttore Finanziario/CFO | - | - |
Ufficiale delle Risorse Umane | - | - |
Formazione di Scott M. Horvitz
State University of New York at Albany | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Posizioni
Director of Finance/CFO | 6 |
Corporate Secretary | 4 |
Treasurer | 4 |
Settori
Health Technology | 6 |
Finance | 2 |
Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 8 |
---|---|
Linguagen Corp.
![]() Linguagen Corp. Pharmaceuticals: OtherHealth Technology Linguagen Corp. researches and develops oral medicines. The firm also develops taste blockers and enhancers. The company was founded by Robert Margolskee in 1995 and is headquartered in Cranbury, NJ. | Health Technology |
Protez Pharmaceuticals, Inc.
![]() Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Protez Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It develops antibiotics for infections & provides research service on intravenous & oral small molecule antibiotics to chronic and recurrent infections. The company was founded by Klaus Esser, Luigi Xerri & Christopher M. Cashman in 2003 and is headquartered in Malvern, PA. | Health Technology |
Robcor Properties, Inc. | Finance |
Redpoint Bio Corp.
![]() Redpoint Bio Corp. Food: Specialty/CandyConsumer Non-Durables Redpoint Bio Corp. is a development stage biotechnology company, which engages in the discovery and development of novel taste modulators for the food, beverage, and pharmaceutical industries. The company was founded by Robert F. Margolskee and Shawn M. Marcell in August 1995 and headquartered in Philadelphia, PA. | Consumer Non-Durables |
3-Dimensional Pharmaceuticals, Inc.
![]() 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | Health Technology |
Genaera Corp.
![]() Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Redpoint Bio Corp. /Old/ | Health Technology |
Opertech Bio, Inc.
![]() Opertech Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opertech Bio, Inc. provides taste testing solutions for food, beverage, flavor ingredients, pet food, and pharmaceutical industries. Its technology can be used to discover new flavor ingredients, measure palatability, and optimize flavor formulations. The firm has developed taste evaluation technology called Microtiter Operant Gustometer, or MOG, an automated high throughput system for rapid characterization of taste sensory properties. The company was founded by Scott M. Horvitz and R. Kyle Palmer and is headquartered in Philadelphia, PA. | Commercial Services |
- Borsa valori
- Insiders
- Scott M. Horvitz
- Esperienza